| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524558 |
NSE Symbol : NEULANDLAB |
P/E(TTM) : 58.55 |
|
ISIN Demat : INE794A01010 |
Div & Yield% : 0.21 |
EPS(TTM) : 283.01 |
|
Book Value(₹) : 1,453.59 |
Market Cap(₹Cr) : 21,260.02 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 776.25 | 439.71 | 514.27 | 292.75 | 328.36 | 398.03 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 776.25 | 439.71 | 514.27 | 292.75 | 328.36 | 398.03 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 12.46 | 8.05 | 1.80 | 7.86 | 7.46 | 59.68 |
| Total Income | 788.71 | 447.76 | 516.07 | 300.61 | 335.82 | 457.72 |
| Total Expenditure | 469.35 | 362.78 | 359.15 | 258.46 | 277.61 | 311.66 |
| PBIDT | 319.36 | 84.98 | 156.92 | 42.15 | 58.22 | 146.06 |
| Interest | 7.23 | 6.79 | 5.34 | 4.58 | 2.35 | 2.22 |
| PBDT | 312.13 | 78.19 | 151.58 | 37.57 | 55.87 | 143.84 |
| Depreciation | 25.09 | 23.92 | 22.54 | 20.19 | 16.89 | 16.30 |
| Tax | 76.80 | 15.21 | 32.51 | 4.37 | 5.94 | 24.92 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -2.28 | -1.35 | 0.07 | -0.70 | 5.31 | 1.23 |
| Reported Profit After Tax | 212.52 | 40.42 | 96.46 | 13.71 | 27.73 | 101.39 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.34 |
| Adjusted Profit After Extra-ordinary item | 212.52 | 40.42 | 96.46 | 13.71 | 27.73 | 57.05 |
| EPS (Unit Curr.) | 165.65 | 31.50 | 75.18 | 10.68 | 21.62 | 79.03 |
| EPS (Adj) (Unit Curr.) | 165.65 | 31.50 | 75.18 | 10.68 | 21.62 | 79.03 |
| Calculated EPS (Unit Curr.) | 164.74 | 31.33 | 74.77 | 10.63 | 21.50 | 78.60 |
| Calculated EPS (Adj) (Unit Curr.) | 164.74 | 31.33 | 74.77 | 10.63 | 21.50 | 78.60 |
| Calculated EPS (Ann.) (Unit Curr.) | 658.96 | 125.31 | 299.09 | 42.50 | 85.99 | 314.39 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 658.96 | 125.31 | 299.09 | 42.50 | 85.99 | 314.39 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 41.14 | 19.33 | 30.51 | 14.40 | 17.73 | 36.70 |
| PBDTM(%) | 40.21 | 17.78 | 29.47 | 12.83 | 17.01 | 36.14 |
| PATM(%) | 27.38 | 9.19 | 18.76 | 4.68 | 8.44 | 25.47 |
